SIM2, associated with clinicopathologic features, promotes the malignant biological behaviors of endometrial carcinoma cells
SIM2 serves as both a biomarker and a therapeutic target for EC diagnosis and prognosis prediction, which positively modulates the malignant phenotypes of EC cells.
Authors
- Hua Nie (ORCID: https://orcid.org/0000-0001-7845-3059)
- Yu Chen (ORCID: https://orcid.org/0000-0001-8678-3787)
Institutions
- Wuhan Children's Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1186/s12885-025-14077-0
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04